Radvanyi; Laszlo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Radvanyi; Laszlo.The latest application filed is for "programmed death 1 ligand 1 (pd-l1) binding proteins and methods of use thereof".

Company Profile

1.13.13

Radvanyi; Laszlo - Acton MA
RADVANYI; Laszlo - Lutz FL
Radvanyi; Laszlo - Houston TX
Radvanyi; Laszlo - Richmond Hill N/A CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Programmed Death 1 Ligand 1 (pd-l1) Binding Proteins And Methods Of Use Thereof App 20220025052 - Rabinovich; Brian ; et al.	2022-01-27
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof Grant 11,141,434 - Rabinovich , et al. October 12, 2	2021-10-12
Programmed Death 1 Ligand 1 (pd-l1) Binding Proteins And Mehtods Of Use Thereof App 20190298770 - Rabinovich; Brian ; et al.	2019-10-03
Biomarkers And Targets For Cancer Immunotherapy App 20170363629 - RADVANYI; Laszlo ; et al.	2017-12-21
B and T lymphocyte attenuator marker for use in adoptive T-cell therapy Grant 9,512,401 - Radvanyi , et al. December 6, 2	2016-12-06
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer Grant 8,946,174 - Berinstein , et al. February 3, 2	2015-02-03
Monoclonal antibodies and uses thereof Grant 8,802,383 - Berinstein , et al. August 12, 2	2014-08-12
B And T Lymphocyte Attenuator Marker For Use In Adoptive T-cell Therapy App 20130302300 - Radvanyi; Laszlo ; et al.	2013-11-14
Monoclonal antibodies and uses thereof Grant 8,361,706 - Berinstein , et al. January 29, 2	2013-01-29
Tumor Antigens for the Prevention and/or Treatment of Cancer App 20130011422 - Berinstein; Neil ; et al.	2013-01-10
Monoclonal Antibodies and Uses Thereof App 20120295275 - Berinstein; Neil ; et al.	2012-11-22
Tumor antigens for prevention and/or treatment of cancer Grant 8,207,314 - Berinstein , et al. June 26, 2	2012-06-26
Tumor antigens Bfa5 for prevention and/or treatment of cancer Grant 8,021,664 - Berinstein , et al. September 20, 2	2011-09-20
Tumor Antigens Bfa4 And Bcy1 For Prevention And / Or Treatment Of Cancer App 20110117640 - Berinstein; Neil ; et al.	2011-05-19
Monoclonal Antibodies and Uses Thereof App 20110045502 - Berinstein; Neil ; et al.	2011-02-24
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer Grant 7,851,213 - Berinstein , et al. December 14, 2	2010-12-14
Tumor Antigen Bfy3 For Prevention And/or Treatment Of Cancer App 20100278848 - Berinstein; Neil ; et al.	2010-11-04
Monoclonal antibodies and uses thereof Grant 7,790,857 - Berinstein , et al. September 7, 2	2010-09-07
Tumor Antigens Bfa5 For Prevention And/Or Treatment Of Cancer App 20080138365 - Berinstein; Neil ; et al.	2008-06-12
Tumor antigen BFA5 for prevention and / or treatment of cancer App 20050112099 - Berinstein, Neil ; et al.	2005-05-26
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer App 20040197912 - Berinstein, Neil ; et al.	2004-10-07

Company Registrations

SEC

0001617953

Radvanyi Laszlo

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.